ArticleNature medicine2025

A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels.

Frederic Tremblay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.